Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

686 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer

NCT00279448

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Marseille, Be1 01971, France
  • Pfizer Investigational Site Compiègne, Be1 02256, France
  • Pfizer Investigational Site Rennes, Be1 03677, France
  • Pfizer Investigational Site Brest, Be1 04292, France
View all 59 locations
View Trial Details
Completed

Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

NCT00471276

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Bakersfield, California, United States
  • Pfizer Investigational Site Burbank, California, United States
  • Pfizer Investigational Site Fountain Valley, California, United States
  • Pfizer Investigational Site Hawthorne, California, United States
View all 31 locations
View Trial Details
Completed

Phase 2 Study of TLK286 in Metastatic Breast Cancer

NCT00035841

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

NCT00243503

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Montgomery, Alabama, United States
  • Pfizer Investigational Site Newark, Delaware, United States
  • Pfizer Investigational Site Newark, Delaware, United States
  • Pfizer Investigational Site Wilmington, Delaware, United States
View all 27 locations
View Trial Details
Completed

Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients

NCT00485979

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Sanofi-Aventis Administrative Office Diegem, Belgium
  • Sanofi-Aventis Administrative Office São Paulo, Brazil
  • Sanofi-Aventis Administrative Office Paris, France
  • Sanofi-Aventis Administrative Office Berlin, Germany
View Trial Details
Completed

Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

NCT00322517

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Pasadena, California, United States
  • Pfizer Investigational Site Santa Monica, California, United States
  • Pfizer Investigational Site Valancia, California, United States
View all 22 locations
View Trial Details
Completed

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

NCT00616135

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Jules Bordet Institute of Cancer Brussels, Belgium
  • Università degli Studi di Firenze Florence, Italy
  • Hospital General Universitario Gregorio Marañon Madrid, Spain
  • Instituto Valenciano Oncologia Valencia, Spain
View Trial Details

Related conditions